Bernard Daugeras

Founder at

Auriga Partners SA

Health Technology

Finance

Consumer Services

Profile

Bernard Daugeras is the founder.
Dr. Daugeras is the founder of Auriga Partners SA, serving as Chairman of the Board since 2010, founded in 1998.
Dr. Daugeras is also the founder of RDS SAS. Dr. Daugeras is currently a Non-Executive Director at Domain Therapeutics SA since 2008, a Director at Isocell Nutra SAS, a Director at Prophesee SA, a Director at IHU Strasbourg, and a Member of the Supervisory Board at Firalis SA. Former positions include Chairman at Sangamo Therapeutics France SAS from 2012 to 2013, Director at Nicox SA, Director at Novagali Pharma SA, Director at MEDIAN Technologies SA, Director at Population Genetics Technologies Ltd., Director at Theranexus SA, Principal at Crédit Lyonnais SA in 1990, Member of the Supervisory Board at Valerio Therapeutics SA, Principal at the University of California, Berkeley, Member of the Supervisory Board at Nemoptic SA, Member of the Supervisory Board at INSERM Transfert SA, Researcher at the University of Orsay, Member of the Supervisory Board at SuperSonic Imagine SA from 2005 to 2015, Principal at Finovelec, Member at Académie des Technologies, and Principal at Centre National de la Recherche Scientifique.
Education includes a doctorate from the University of Orsay and an undergraduate degree from Ecole Polytechnique.

Bernard Daugeras active positions

Companies	Position	Start
Auriga Partners SA Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes.	Founder	12/06/1998
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Director/Board Member	01/01/2008
Isocell SA Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements	Director/Board Member	-
Firalis SA Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics	Director/Board Member	-
IHU Strasbourg IHU Strasbourg Hospital/Nursing ManagementHealth Services Provides medical and surgical center services	Director/Board Member	-
Prophesee SA Prophesee SA Medical SpecialtiesHealth Technology Develops vision sensors and systems	Director/Board Member	-

All active positions of Bernard Daugeras

Former positions of Bernard Daugeras

Companies	Position	End
SUPERSONIC IMAGINE	Director/Board Member	26/02/2015
Crédit Lyonnais SA Crédit Lyonnais SA Major BanksFinance Provides banking services	Corporate Officer/Principal	01/01/1990
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Director/Board Member	-
░░░ ░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Bernard Daugeras's experience

Training of Bernard Daugeras

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bernard Daugeras's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	24
Crédit Lyonnais SA Crédit Lyonnais SA Major BanksFinance Provides banking services	Finance
Nicox SA Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals	Health Technology
Auriga Partners SA Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes.	Finance
Valerio Therapeutics SA Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products	Health Technology
Novagali Pharma SA Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment	Health Technology
MEDIAN Technologies SA MEDIAN Technologies SA Medical/Nursing ServicesHealth Services Engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology	Health Services
Nemoptic SA Nemoptic SA Electronic Production EquipmentElectronic Technology Designs and manufactures liquid crystal displays (LCD) for consumer and professional mobile devices	Electronic Technology
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
University of Orsay University of Orsay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SuperSonic Imagine SA SuperSonic Imagine SA Medical SpecialtiesHealth Technology Develops and manufactures ultrasound systems & medical imaging devices	Health Technology
Ecole Polytechnique Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Finovelec
Académie des Technologies Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France.
Sangamo Therapeutics France SAS Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases	Health Technology
Population Genetics Technologies Ltd. Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Offers population genetics studies	Commercial Services
Centre National de la Recherche Scientifique Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services	Government
Isocell SA Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements	Retail Trade
Firalis SA Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics	Health Technology
Theranexus SA Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases	Health Technology
Prophesee SA Prophesee SA Medical SpecialtiesHealth Technology Develops vision sensors and systems	Health Technology
IHU Strasbourg IHU Strasbourg Hospital/Nursing ManagementHealth Services Provides medical and surgical center services	Health Services
Rds SAS Rds SAS Packaged SoftwareTechnology Services Provides real-time monitoring solutions for healthcare industry	Technology Services